Cox 2 Inhibitor News and Research

RSS
Cox-2 Inhibitors are nonsteroidal anti-inflammatory drugs used to relieve pain and inflammation. COX-2 inhibitors are being studied in the prevention of colon polyps, and as anticancer drugs. Also called cyclo-oxygenase-2 inhibitor.
NSAIDs may not be safe for arthritis patients with cardiovascular risk, study shows

NSAIDs may not be safe for arthritis patients with cardiovascular risk, study shows

Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

LSU Health New Orleans finalizes deal with CB BioSciences

LSU Health New Orleans finalizes deal with CB BioSciences

New oral medication shows promise in treating fibromyalgia

New oral medication shows promise in treating fibromyalgia

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine

Researchers create combination drug that controls both tumor growth and metastasis

Researchers create combination drug that controls both tumor growth and metastasis

Effective strategy for noninvasive detection of cancer

Effective strategy for noninvasive detection of cancer

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

COX-2 inhibitor extends sunitinib activity in renal cell carcinoma

COX-2 inhibitor extends sunitinib activity in renal cell carcinoma

Positive results from CrystalGenomics’ CG100649 Phase 2b OA study

Positive results from CrystalGenomics’ CG100649 Phase 2b OA study

Decreasing GPA adherence among COX-2 users increases risk of upper GI complications

Decreasing GPA adherence among COX-2 users increases risk of upper GI complications

Aspirin may benefit HIV-infected women at risk of cervical cancer

Aspirin may benefit HIV-infected women at risk of cervical cancer

NSAIDs like ibuprofen slow the spread of breast cancers

NSAIDs like ibuprofen slow the spread of breast cancers

Former smokers with lung cancer can benefit from celecoxib treatment

Former smokers with lung cancer can benefit from celecoxib treatment

Change in diet can reduce cancer risk

Change in diet can reduce cancer risk

Tragara's apricoxib-erlotinib Phase 2 study data on non-small cell lung cancer presented at ASCO 2011

Tragara's apricoxib-erlotinib Phase 2 study data on non-small cell lung cancer presented at ASCO 2011

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

Research finds 'no safe window' for painkiller use among heart attack survivors

Research finds 'no safe window' for painkiller use among heart attack survivors